#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Neonatal alloimmune thrombocytopenia Mantle cell lymphoma Turner's syndrome Fungal infection Philadelphia positive chronic myeloid leukaemia Vulval cancer Acute myeloid leukaemia refractory Dementia with Lewy bodies Dementia Alzheimer's type Tourette's disorder Duchenne muscular dystrophy Crigler-Najjar syndrome HER2 gene amplification Synovial sarcoma More trials…

    Learn about Rare Diseases

    KBG syndrome Immunodeficiency congenital MELAS syndrome – Basic Information Stevens-Johnson syndrome – Basic Information Fragile X syndrome – Diagnostics Erdheim-Chester disease – Diagnostics Sjogren’s syndrome – Basic Information Alexander disease Vascular malformation – Treatment Pemphigus – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PRT3789 GSKVX000000030810 Narsoplimab Triamcinolone Acetonide Suxamethonium Chloride Vinblastine Sulfate Eribulin Mesylate H2-Receptor Antagonist E.coli Polysaccharide Betamethasone Dipropionate Ads-010 Sebetralstat Capsaicin Cefuroxime Talquetamab Arginine Ecoo18A TX000045 Clofarabine PRILOCAINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Soft tissue sarcoma Bronchiectasis Crigler-Najjar syndrome White matter lesion Ischaemic skin ulcer Undifferentiated sarcoma Catatonia Breast cancer male Arrhythmia Cardiac failure congestive Bacterial infection Sepsis Pyoderma Multifocal motor neuropathy Embolic stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary sarcoidosis

  • Study on Methotrexate and Prednisone for Treating Lung Sarcoidosis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary sarcoidosis
    Investigated Drugs:
    • Methotrexate
    • Prednisone
    The Netherlands

  • Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

    Recruiting

    2 1
    Investigated Drugs:
    • 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine
    Denmark France Germany Greece The Netherlands Norway

  • Study of hydroxychloroquine with low-dose corticosteroids compared to medium-dose corticosteroids in patients with pulmonary sarcoidosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone
    • Hydroxychloroquine Sulfate
    • Prednisone
    France

  • Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Pulmonary sarcoidosis
    Investigated Drugs:
    • 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine
    Denmark France Germany Greece Norway Poland

  • Study on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary sarcoidosis
    Investigated Drugs:
    • Efzofitimod
    France Germany Italy The Netherlands Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!